At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...
One of the secrets to living a longer, better life is beating in our chests. An estimated 80% of cardiovascular disease (CVD) can be prevented with lifestyle changes and available tools, yet it ...
Die hier zur Verfügung gestellten Informationen sollen eine sichere und effektive Anwendung von Itvisma unterstützen. Sie sollen sicherstellen, dass Ärzte und Apotheker sowie Patienten die besonderen ...
Reshema Kemps-Polanco is Executive Vice President and Chief Commercial Officer, Novartis US, responsible for the expansion of medicines across oncology, immunology, neurology, and cardiovascular, ...
Novartis has had a significant footprint in India since 1947, with two legal entities namely, Novartis Healthcare Private Limited, and Novartis India Limited. India is amongst a handful of countries ...
Novartis Ireland Structure Giulia Conti Country President Novartis Ireland & Managing Director Novartis International (Pharma) Eamon Boland Head Novartis Corporate Centre, Dublin ...
Weil wir Ihr Wissen wertschätzen und Talente fördern, um auch in Zukunft die Gesundheit und das Wohlbefinden der Menschen auf höchstem Niveau zu verbessern. Es gibt viele Gründe, sich für Novartis zu ...
Acute myeloid leukemia (AML), the most common form of acute leukemia in adults, is a cancer of the blood and bone marrow. Prognosis and survival rate may depend on numerous factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results